PROXEON BIOSYSTEMS ApS: Financial statements 2019
CVR: 26848024
PROXEON BIOSYSTEMS ApS (CVR 26848024) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 42,034,000 and a net result of DKK 32,332,000 compared with DKK 36,246,000 the year before. That is a decrease of 11.9% compared with the year before. Equity amounted to DKK 317,383,000. The solvency ratio was 97.1%.
- Gross Profit
- 42,034,000 kr.
- Profit/Loss
- 32,332,000 kr.
- Equity
- 317,383,000 kr.
- Total Assets
- 327,010,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 42 mio. | 32.3 mio. | 317.4 mio. | - |
| 2018 | - | 47.7 mio. | 36.2 mio. | 285.1 mio. | - |
| 2017 | - | 38 mio. | 29.5 mio. | 248.8 mio. | - |
| 2016 | - | 39.9 mio. | 31.1 mio. | 219.3 mio. | - |
| 2015 | - | 64 mio. | 50.1 mio. | 188.2 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
PROXEON BIOSYSTEMS ApS has published its annual report for 2018. Gross profit came to DKK 47,689,000, and the net result was DKK 36,246,000.
About PROXEON BIOSYSTEMS ApS
PROXEON BIOSYSTEMS ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Lie. The company is owned by NUNC A/S. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 2,950,000 compared with DKK 3,703,000 the year before. Equity amounted to DKK 386,590,000.
